(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and ...
A poll from the health policy nonprofit KFF found that 1 in 8 adults say they’ve taken a GLP-1 agonist, the obesity and ...
A new KFF health tracking survey found that one in eight U.S. adults have taken Ozempic or a similar GLP-1 drug at some point ...
The majority — 62 percent — said they were using the drugs to treat a chronic condition like diabetes or heart disease while ...
KFF poll results suggest about 12 percent of adults in the U.S. have tried a GLP-1 drug like Ozempic to manage chronic health ...
I’M MINDY BASARA IN TODAY’S MEDICAL ALERT, WEIGHT LOSS AND DIABETES DRUGS LIKE OZEMPIC WEGOVY AND ZYBAN ARE ALL THE RAGE RIGHT NOW. AND TO HELP BETTER UNDERSTAND WHAT’S HAPPENING WITH THESE ...
I’M MINDY BASARA IN TODAY’S MEDICAL ALERT, WEIGHT LOSS AND DIABETES DRUGS LIKE OZEMPIC WEGOVY AND ZYBAN ARE ALL THE RAGE RIGHT NOW. AND TO HELP BETTER UNDERSTAND WHAT’S HAPPENING WITH THESE ...
About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half of them – about 6% of adults, or more than 15 million people – are ...